Quest Diagnostics 2013 Annual Report Download - page 26

22
Jon R. Cohen, M.D. (59) is Senior Vice President and Chief Medical Officer. Dr. Cohen joined the company in March
2009 and serves as Chief Medical Officer. From May 2011 to January 2013, he also had responsibility for Hospital Services. In
January 2013, Dr. Cohen assumed responsibility for cancer diagnostic, pathology services, sports diagnostics and laboratory
professional services. In February 2014, he also assumed responsibility for our clinical trials business. He served as the Senior
Adviser to New York Governor David Patterson from 2008 to 2009, where he was responsible for all policy and strategic
planning. From 2007 to 2008, Dr. Cohen was a managing director, health industries advisory services at
PricewaterhouseCoopers LLP. Prior to that, he spent 21 years with North Shore-Long Island Jewish Health System, one of the
nation's largest not-for-profit health systems, including serving as its Chief Medical Officer from 2000 to 2006.
Everett V. Cunningham (47) is Senior Vice President, Commercial. Mr. Cunningham is responsible for the commercial
organization for the Company's Diagnostic Information Services business. Mr. Cunningham joined the Company in October
2012. Previously, Mr. Cunningham was with Pfizer, Inc., where he served in a series of sales and leadership and general
management roles for 21 years. From June 2011 to October 2012, he served as Regional President, Established Products, Asia.
From 2009 to 2011, Mr. Cunningham served as Regional President, West Business Unit, Primary Care. From 2007 to 2009, he
served as Vice President, Human Resources, Corporate Groups. From 2003 to 2007, Mr. Cunningham was Vice President,
Sales, U.S. Pharmaceuticals, Pain and Musculoskeletal Division.
James E. Davis (51) has been Senior Vice President, Operations since February 2014. He is responsible for operations
for the Company's Diagnostic Information Services business, and for our diagnostic products business. He joined Quest
Diagnostics in April 2013 as Senior Vice President, Diagnostics Solutions, with responsibility for the Company’s healthcare IT,
insurer services, clinical trials, diagnostic products and employer solutions businesses. Prior to joining Quest Diagnostics, from
March 2012 to April 2013, Mr. Davis served as Lead Director, and then as Chief Executive Officer, of InSightec, Inc., a
medical device company that designs and develops ultrasound ablation devices that are guided by magnetic resonance imaging
systems. Previously, Mr. Davis held a number of senior positions in General Electric’s healthcare business, including from
2007 to 2012 as Vice President and General Manager of GE Healthcare’s magnetic resonance imaging business. Prior to
joining GE Healthcare, Mr. Davis held leadership positions in GE’s aviation business and led the development of strategic and
operational improvement initiatives for clients of McKinsey & Company, Inc.
Catherine T. Doherty (51) is Senior Vice President, Clinical Franchises. She is responsible for overseeing the
development of clinical franchise solutions in the areas of cardiovascular, infectious disease and immunology, neurology,
prescription drug monitoring and toxicology, women's health and general wellness, as well as enterprise-wide strategic
marketing and business development. In February 2014, Ms. Doherty assumed responsibility for our employer solutions,
healthcare information technology and life insurer services businesses. From May 2011 to December 2012, she served as
Senior Vice President, Physician Services. From 2008 through May 2011, Ms. Doherty served as Vice President, Hospital
Services. Prior to 2008, Ms. Doherty held a variety of positions of increasing responsibility since joining the Company in
1990, including Vice President, Office of the Chairman; Vice President, Finance and Administration for the Hospital business;
Vice President, Communications and Investor Relations; and Chief Accounting Officer.
Mark J. Guinan (52) is Senior Vice President and Chief Financial Officer. He joined the Company in July 2013.
From 2010 until joining Quest Diagnostics in 2013, Mr. Guinan served as Chief Financial Officer for Hill-Rom Holdings Inc., a
manufacturer and provider of medical technologies and related services for the health care industry. Previously, he had served
in a number of finance and operations roles in a long career at Johnson & Johnson including 2009 to 2010 as Vice President,
Chief Procurement Officer, and 2005 to 2009 as Vice President, Group Finance Pharmaceuticals. Before joining Johnson and
Johnson in 1997, he held a number of financial roles at Procter & Gamble.
Michael E. Prevoznik (52) is Senior Vice President and General Counsel. Mr. Prevoznik joined the Company as Vice
President and General Counsel in August 1999. In 2003, he assumed responsibility for governmental affairs. From 1999 until
April 2009, Mr. Prevoznik also had responsibility for the Company's Compliance Department. Since April 2011, in addition to
serving as General Counsel, Mr. Prevoznik has had management responsibility for the Company's diagnostic information
services activities outside the U.S. In addition, from April 2011 to January 2013, Mr. Prevoznik had management responsibility
for the Company's clinical trials business. Prior to joining the Company, Mr. Prevoznik served in positions of increasing
responsibility within the compliance organization at SmithKline Beecham, most recently as Vice President, Compliance, with
responsibility for coordinating all SmithKline Beecham compliance activities worldwide.